Is it time to remove ‘cancer’ label from low-risk prostate tumors?May 6, 2022Genitourinary CancerOncologyProstate Cancer
Cancer Data Trends 2022March 30, 2022Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerProstate CancerHospice & Palliative MedicineOncology
MRI far safer than CT for guiding radiotherapy in prostate cancerFebruary 24, 2022Genitourinary CancerOncologyProstate Cancer
Urine test for prostate cancer signals amount of aggressive tumorNovember 11, 2021Genitourinary CancerProstate CancerOncology
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-free DNASeptember 10, 2021Prostate CancerColon and RectalOncology
Methods of Identifying Real World mCRPC Patients from the Veterans Health Administration SystemSeptember 9, 2021Prostate CancerColon and Rectal
Diagnosis of Prostate Cancer and Prostate-specific Antigen Level on Initial Prostate Biopsy: Does Race Matter?September 9, 2021Prostate CancerColon and Rectal
Old saying about prostate cancer not true when it’s metastaticSeptember 7, 2021Genitourinary CancerProstate CancerOncology
Health-Related Quality of Life and Toxicity After Definitive High-Dose-Rate Brachytherapy Among Veterans With Prostate CancerAugust 18, 2021Prostate CancerOncology
Bone Health in Patients With Prostate Cancer: An Evidence-Based AlgorithmAugust 18, 2021Colon and RectalMixed TopicsProstate Cancer
The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration(FULL)August 2, 2021OncologyProstate Cancer
Healthy lifestyle may offset genetic risk in prostate cancerApril 13, 2021Genitourinary CancerOncologyProstate Cancer
CCR score can guide treatment decisions after radiation in prostate cancerFebruary 13, 2021Genitourinary CancerProstate CancerOncology
Declines in PSA screening may account for rise in metastatic prostate cancersFebruary 12, 2021Genitourinary CancerOncologyProstate Cancer
Liquid Biopsies in a Veteran Patient Population With Advanced Prostate and Lung Non-Small Cell Carcinomas: A New Paradigm and Unique Challenge in Personalized MedicineJanuary 7, 2021Lung CancerOncologyProstate Cancer
